Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_assertion type Assertion NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_head.
- NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_provenance.
- NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_assertion evidence source_evidence_literature NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_provenance.
- NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_assertion SIO_000772 22587513 NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_provenance.
- NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_assertion wasDerivedFrom befree-20140225 NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_provenance.
- NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_assertion wasGeneratedBy ECO_0000203 NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_provenance.